From: A telemonitoring programme in patients with heart failure in France: a cost-utility analysis
N° | Variable | Category | Value | Source |
---|---|---|---|---|
Model population | ||||
1 | Age group | < 70 years | 56.0% | SCAD cohort [19] |
≥ 70 years | 44.0% | SCAD cohort [19] | ||
2 | Severity | NYHA I/II | 61.0%a | SCAD cohort [19] |
NYHA III/IV | 39.0% | SCAD cohort [19] | ||
3 | Extent of use of programme | Intermediate | 50.4% | SCAD cohort [19] |
High | 49.6% | SCAD cohort [19] | ||
4 | Number of hospitalisations for HF | 0 in previous 12 months | 52.1% | SCAD cohort [19] |
1 in previous 12 months | 36.0% | SCAD cohort [19] | ||
≥ 2 in previous 12 months | 11.9% | SCAD cohort [19] | ||
Transition probabilities | ||||
5 | Not hospitalised with no previous hospitalisation for HF to first hospitalisation for HF | 0.006 | ODIN study [25] | |
6 | Not hospitalised with one previous hospitalisation for HF to rehospitalisation for HF | 0.017 | AMELI study [28] | |
7 | Not hospitalised with ≥ 2 previous hospitalisations for HF to rehospitalisation for HF | 0.017 | AMELI study [28] | |
8 | Not hospitalised with no previous hospitalisation for HF to death | 0.0066 | ODIN study [25] | |
9 | Not hospitalised with one previous hospitalisation for HF to death | 0.0085 | ODIN study [25] | |
10 | Not hospitalised with ≥ 2 previous hospitalisations for HF to death | 0.0181 | ODIN study [25] | |
11 | First hospitalisation for HF to death (assumption) | 0.0085 | Equivalent to n° 9 | |
12 | Rehospitalisation for HF to death (assumption) | 0.0181 | Equivalent to n° 10 | |
Adjustment factors (relative risk) | ||||
13 | Age < 70 years and NYHA I/II: risk of hospitalisation for HF | 0.79 | ODIN study [25] | |
Age < 70 years and NYHA III/IV: risk of hospitalisation for HF | 1.43 | ODIN study [25] | ||
Age ≥ 70 years and NYHA I/II: risk of hospitalisation for HF | 0.74 | ODIN study [25] | ||
Age ≥ 70 years and NYHA III/IV: risk of hospitalisation for HF | 1.32 | ODIN study [25] | ||
14 | Age < 70 years and NYHA I/II: risk of death | 0.76 | ODIN study [25] | |
Age < 70 years and NYHA III/IV: risk of death | 1.48 | ODIN study [25] | ||
Age ≥ 70 years and NYHA I/II: risk of death | 0.71 | ODIN study [25] | ||
Age ≥ 70 years and NYHA III/IV: risk of death | 1.36 | ODIN study [25] | ||
Efficacy of intervention (relative risk) | ||||
15 | Risk of hospitalisation for HF | 0.500 | SCAD cohort [19] | |
Risk of death | 0.535 | SCAD cohort [19] |